Regeneron (REGN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $14.29
- EPS estimate
- $10.16
- EPS surprise
- +40.69%
- Revenue surprise
- +12.40%
- Revenue
- $4.3B
- Revenue estimate
- $3.8B
- Reported
- Jul 30, 2026
Regeneron reported Q2 2026 results on July 30, 2026. Earnings per share came in at $14.29, ahead of the $10.16 estimate by 40.69%. Revenue was $4.3 billion, 12.4% above the $3.8 billion consensus. Compared with Q2 2025, EPS rose about 11% from $12.89 and revenue rose about 16% from $3.7 billion. Both were the highest quarterly figures since Q4 2021.
The longer record shows earnings holding in a narrow band while revenue grew. Annual EPS was $44.96 in 2022, $43.78 in 2023, $45.64 in 2024 and $44.38 in 2025. Annual revenue rose about 18% over that span, from $12.2 billion to $14.4 billion. The first half of 2026 adds up to $23.76 per share, about 13% more than a year earlier, on revenue up about 18%. Q4 2021 holds the highs in the table, at $23.72 per share and $5.0 billion in revenue. The low was Q1 2025, at $8.22. Over the last 20 quarters, Regeneron topped the EPS estimate 18 times. Both misses came in first quarters.
Regeneron reported Q3 results between October 28 and November 4 in each of the past five years. That points to late October or early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $10.16 | $14.29 | +40.69% | $4.3B | SEC |
| Q1 2026 | Apr 29, 2026 | $8.91 | $9.47 | +6.24% | $3.6B | SEC |
| Q4 2025 | Jan 30, 2026 | $10.74 | $11.44 | +6.56% | $3.9B | SEC |
| Q3 2025 | Oct 28, 2025 | $9.65 | $11.83 | +22.53% | $3.8B | SEC |
| Q2 2025 | Aug 1, 2025 | $8.43 | $12.89 | +52.89% | $3.7B | SEC |
| Q1 2025 | Apr 29, 2025 | $8.62 | $8.22 | −4.66% | $3.0B | SEC |
| Q4 2024 | Feb 4, 2025 | $11.28 | $12.07 | +6.98% | $3.8B | SEC |
| Q3 2024 | Oct 31, 2024 | $11.70 | $12.46 | +6.54% | $3.7B | SEC |
| Q2 2024 | Aug 1, 2024 | $10.62 | $11.56 | +8.87% | $3.5B | SEC |
| Q1 2024 | May 2, 2024 | $10.17 | $9.55 | −6.11% | $3.1B | SEC |
| Q4 2023 | Feb 2, 2024 | $10.73 | $11.86 | +10.52% | $3.4B | SEC |
| Q3 2023 | Nov 2, 2023 | $10.68 | $11.59 | +8.50% | $3.4B | SEC |
| Q2 2023 | Aug 3, 2023 | $9.85 | $10.24 | +3.99% | $3.2B | SEC |
| Q1 2023 | May 4, 2023 | $9.52 | $10.09 | +5.99% | $3.2B | SEC |
| Q4 2022 | Feb 3, 2023 | $10.25 | $12.56 | +22.57% | $3.4B | SEC |
| Q3 2022 | Nov 3, 2022 | $9.76 | $11.14 | +14.17% | $2.9B | SEC |
| Q2 2022 | Aug 3, 2022 | $8.62 | $9.77 | +13.36% | $2.9B | SEC |
| Q1 2022 | May 4, 2022 | $9.72 | $11.49 | +18.15% | $3.0B | SEC |
| Q4 2021 | Feb 4, 2022 | $20.40 | $23.72 | +16.26% | $5.0B | SEC |
| Q3 2021 | Nov 4, 2021 | $10.35 | $15.37 | +48.57% | $3.5B | SEC |
Quarterly revenue
Frequently asked questions
When did Regeneron (REGN) last report earnings?
Regeneron last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did REGN beat earnings estimates?
Yes. Regeneron reported EPS of $14.29 for Q2 2026 against a $10.16 estimate — a 40.69% beat.
How much revenue did REGN report last quarter?
Regeneron reported $4.3B in revenue for Q2 2026, against a consensus estimate of $3.8B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.